This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
The 5 Hottest Earnings Charts This Week
by Tracey Ryniec
The 5 stocks have had the sizzle over the last 5 years. Will it continue this week?
The Zacks Analyst Blog Highlights: JP Morgan, UnitedHealth, Lockheed Martin and BHP Billiton
by Zacks Equity Research
The Zacks Analyst Blog Highlights: JP Morgan, UnitedHealth, Lockheed Martin and BHP Billiton
UnitedHealth (UNH) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
UnitedHealth's (UNH) second-quarter results are expected to be boosted by the revenue growth at UnitedHealthcare and Optum segments and increasing membership.
Dow ETF Appears Strong Ahead of Q2 Earnings
by Sweta Killa
With most blue-chip companies' earnings scheduled over the coming weeks and investors' sentiment being mixed, investors should closely monitor the movement of the Dow ETF.
New Earnings Season Opens: Global Week Ahead
by John Blank
The dominant trader focus inside the Global Week Ahead will surely be the Q2 earnings season -- with the usual early focus upon Financials.
The Zacks Analyst Blog Highlights: Microsoft, UnitedHealth, Costco, Uber and Microchip Technology
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, UnitedHealth, Costco, Uber and Microchip Technology
Is UnitedHealth Group (UNH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (UNH) Outperforming Other Medical Stocks This Year?
Cigna Stock Gains Near 9% on Drug Rebate Proposal Pullback
by Zacks Equity Research
Cigna's (CI) Pharmacy Benefits management is poised to gain due to the pullback of the drug rebate proposal.
Is UnitedHealth (UNH) Stock a Buy Heading into Q2 2019 Earnings?
by Benjamin Rains
Shares of UnitedHealth Group (UNH) popped Friday after they surged Thursday to help spur the Dow Jones Industrial Average's rally. But should investors consider buying UNH stock ahead of its Q2 earnings results?
ETFs to Shine as Trump Tosses Drug Rebate Curb Plan
by Sweta Jaiswal, FRM
We study the impact of Trump's dropping of the proposed drug rebate rule on some health ETFs with exposure to pharmacy benefit managers and healthcare insurers.
Dow Breezes Past 27,000: 4 Blue-Chip Stocks to Buy
by Tirthankar Chakraborty
The 30-stock index closes above the 27,000 mark for the first time. It took nearly 372 days for the blue-chip index to cross the 27,000 mark from when it reached the 26,000 mark in January 2018.
Health Insurers Rejoice on Pullback of Drug Rebate Plan
by Sapna Bagaria
After many regulatory disturbances and overhang of the drug rebate ban proposal, a repeal of it is a breather for health insurers.
Dow 30 Stock Roundup: Cisco to Buy Acacia, Microsoft & ServiceNow Partnernership
by Swarup Gupta
The index endured a turbulent week but gained after the Fed Chair indicated that a rate was likely later this month.
Top Analyst Reports for Microsoft, UnitedHealth & Costco
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), UnitedHealth (UNH) and Costco (COST).
Trump Drops Drug Rebate Proposal: What's Next and What Stocks to Play
by Christopher Vargas
The Trump administration announced Thursday that it's deciding to withdraw its proposal to eliminate rebates from government drug plans.
3 Health-Insurance Stocks to Consider When the Fed Drops Rates
by Mitchell Moore
The next Federal Reserve Open Market Committee meeting is set for July 30-31, where they will decide whether or not to cut interest rates. The market assumes a 100% probability that the Fed cuts rates by at least a quarter point, according to analysts.
UnitedHealth Group (UNH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $246 in the latest trading session, marking a -0.74% move from the prior day.
Molina (MOH) Stock Surges 34% in a Year: More Room to Run
by Zacks Equity Research
Molina's (MOH) restructuring plan should aid revenue growth. This will likely drive its share price further.
The Zacks Analyst Blog Highlights: Amazon, UnitedHealth, AbbVie, Simon Property and Autodesk
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, UnitedHealth, AbbVie, Simon Property and Autodesk
Centene (CNC) Acquires Additional Stake in Ribera Salud
by Zacks Equity Research
Centene (CNC) buys a surplus share in Ribera Salud to fortify its footprint in Europe.
Top Stock Reports for Amazon, UnitedHealth & AbbVie
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Amazon (AMZN), UnitedHealth (UNH) and AbbVie (ABBV).
UnitedHealth's Stock Down in 1H19: What Lies Ahead in 2H?
by Zacks Equity Research
Regulatory disturbances weigh on UnitedHealth's (UNH) stock in the first half of 2019. However, the company is likely to get support from its strong business model.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $242.64, marking a -0.56% move from the previous day.
The Zacks Analyst Blog Highlights: NIKE, Walgreens Boots Alliance, UnitedHealth, Pfizer and Home Depot
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NIKE, Walgreens Boots Alliance, UnitedHealth, Pfizer and Home Depot